NEOPLASM RECURRENCE, LOCAL
Clinical trials for NEOPLASM RECURRENCE, LOCAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM RECURRENCE, LOCAL trials appear
Sign up with your email to follow new studies for NEOPLASM RECURRENCE, LOCAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for recurrent endometrial cancer: drug combo shows promise
Disease control Recruiting nowThis study tests a new combination of the drug cadonilimab plus chemotherapy and radiation for people whose endometrial cancer has come back or spread to a few other spots. About 30 participants will receive the treatment and be monitored for tumor shrinkage, survival, and side e…
Matched conditions: NEOPLASM RECURRENCE, LOCAL
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New triple-drug attack targets hard-to-treat head and neck cancers
Disease control Recruiting nowThis early-phase study tests a new three-drug combination (zanzalintinib, pembrolizumab, and cetuximab) in adults with recurrent or metastatic head and neck cancer that cannot be cured by local treatments. The main goal is to find the safest dose and check for early signs of tumo…
Matched conditions: NEOPLASM RECURRENCE, LOCAL
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:05 UTC